Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Ezrin expression was associated with pT stage (P < 0.001), clinical stage (P = 0.012), synchronic metastasis (P < 0.001), incidental tumors (P = 0.007), and International Society of Urological Pathology histological grade (P = 0.025).
|
31648868 |
2020 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Tetraspanin CD82 interaction with cholesterol promotes extracellular vesicle-mediated release of ezrin to inhibit tumour cell movement.
|
31807237 |
2020 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Our findings demonstrate that the tumor ezrin level act as an independent biomarker in predicting relapse and provide a rationale for therapeutic targeting of ezrin to reduce the metastatic capacity of cancer cells in high-risk BC patients with elevated ezrin expression.
|
30678714 |
2019 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
EZR expression level in tumor tissue was significantly upregulated compared to that of normal breast tissue of breast cancer patients (P < 0.05).
|
31452341 |
2019 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Pooled analyses showed that ezrin overexpression was correlated with a higher rate of tumor metastasis (OR 6.59, 95% CI: 2.84-15.33, P < 0.01, P<sub>FDR</sub> < 0.01) and recurrence (OR 3.18, 95% CI: 1.88-5.37, P < 0.01, P<sub>FDR</sub> < 0.01) and a more advanced tumor grade (OR 3.252, 95% CI: 1.371-7.715, P = 0.01, P<sub>FDR</sub> = 0.03).
|
31376222 |
2019 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Furthermore, Ezrin and MMP-9 protein levels were negatively associated with miR-183 expression, indicating that miR-183 may function as a tumor suppressor by inhibiting the expression of these two proteins.
|
30655800 |
2019 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
From this cohort, we tested the predictive value of common clinicopathological parameters (ulceration, mitotic count and tumor regression) and FMNL-2, ezrin and BRAF V600E immunoreactivity, for sentinel node involvement and survival.
|
31039200 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Our data indicate that Ezrin represents a promising therapeutic target for patients bearing tumors with activated HGF/Met signaling.
|
29210059 |
2018 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Tumor tissues were taken from the osteosarcoma patients with chemotherapy resistance to detect the expression levels of PAK5 and Ezrin via immunohistochemical detection, and the correlation between PAK5 and Ezrin expressions was studied.
|
29391894 |
2018 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The neurofibromatosis type 2 (NF2) tumor suppressor merlin and closely related membrane:cytoskeleton-linking protein ezrin organize the membrane:cytoskeleton interface, a critical cellular compartment that both regulates and is regulated by growth factor receptors.
|
30143526 |
2018 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The mRNA expression of Ezrin was correlated with tumor size, lymphatic metastasis, pathological grade and clinical stage (FIGO).
|
30282070 |
2018 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Although suppressing ezrin expression with small interfering RNA transfection caused no marked changes in morphology, cell projection formation was decreased, and the tumour thickness in vertical sections after 3D culture was markedly decreased after suppressing ERK activity because both the invasion ability and proliferation were inhibited.
|
30344309 |
2018 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
In univariate analysis patients having microsatellite instabile / low ezrin expression tumors had a significantly longer disease-specific survival than patients having microsatellite stable / high ezrin expression tumors (p = 0.007).
|
28953975 |
2017 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
There are a lot of cytokines inducing EMT of tumor cells, EGF is one of the important cytokines.Ezrin is a connexin between the cytoskeleton and the cell membrane, which is closely related to the morphological movement and metastasis of tumor cells.EGF can activate Ezrin and affects cell motility.
|
28535417 |
2017 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Ezrin expression is significantly associated with tumor grade, TNM stage, and lymph node metastasis in gastric and colorectal cancers.
|
29190988 |
2017 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Tumor-associated macrophages promote Ezrin phosphorylation-mediated epithelial-mesenchymal transition in lung adenocarcinoma through FUT4/LeY up-regulation.
|
28423676 |
2017 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
We also evaluated the correlation between the mRNA expression of the WWOX gene and genes involved in the processes of carcinogenesis, namely catenin beta-1 (CTNNB1) and zinc finger E-box binding homeobox 1 (ZEB1) (gene transcription), cadherin 1 (CDH1) and ezrin (EZR) (cell adhesion), vimentin (VIM) (structural proteins), as well as phosphatase and tensin homolog (PTEN) (tumor suppression) and secreted protein, acidic, cysteine-rich (osteonectin) (SPARC) (SPARC) (cell growth regulation) by RT-qPCR.
|
26820701 |
2016 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
BACKGROUND Ezrin-radixin-moesin (ERM) plays an important role in multiple links of tumors.
|
27276064 |
2016 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The Ezrin expression was associated with the metastasis status of the patients (P < 0.05) but not associated with the age (P > 0.05), gender (P > 0.05), differentiation (P > 0.05), and tumor diameter (P > 0.05).
|
28230040 |
2016 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
These results implicate Ezrin as an EMT regulator and tumor promoter in cervical cancer, and down-regulation of Ezrin suppressed cervical cancer progression, possibly via the phosphoinositide 3-kinase/Akt pathway.
|
26933912 |
2016 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Prognostic and predictive role of CXCR4, IGF-1R and Ezrin expression in localized synovial sarcoma: is chemotaxis important to tumor response?
|
25613038 |
2015 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
MiR-144 and Ezrin mRNA expressions were significantly related with cell metastasis (P < 0.05) but were not related with other clinical factors such as gender, age, tumor location, tumor size, Enneking staging, and Dahlin's histological classification.
|
25854173 |
2015 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Here, we show that primary DLBCL tumors and patient-derived DLBCL cell lines contain high levels of phosphorylated Ezrin-Radixin-Moesin (ERM) proteins.
|
25801911 |
2015 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
MicroRNA-183 (miR-183) has been demonstrated to be a tumor suppressor miRNA in inhibition of migration and invasion of osteosarcoma by targeting an oncogene Ezrin.
|
24352761 |
2014 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
We identified increased expression of p-ezrin T567 in CRC liver metastasis in both orthotopically implanted GEO tumors as well as human patient specimens.
|
24462708 |
2014 |